Applications are now open for the 2026 Eric Dostie Memorial College Scholarships, which will award $1,000 each to 10 qualifying students whose lives have…
Von Willebrand disease
A 3-year-old boy in Texas was the first known person with two bleeding disorders — type 1 von Willebrand disease (VWD) and hemophilia…
The rare coexistence of von Willebrand disease (VWD) type 3 and factor V Leiden (FVL) can put patients at risk for…
Heavy menstrual bleeding (HMB) affects 93% of women with von Willebrand disease (VWD) at some point in life, according to a Swedish study that…
Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose defect causes the disease, increasing…
Star Therapeutics has raised $125 million to support the development of VGA039, a treatment for von Willebrand disease (VWD) and other bleeding disorders…
Excessive bleeding from a common skin abnormality was the first indication of von Willebrand disease (VWD) in a 1-year-old girl, highlighting the importance of…
Although more people with von Willebrand disease (VWD) have given birth over the past two decades, the rates of certain complications, such as prebirth…
Adding Cyklokapron (tranexamic acid) to Vonvendi (recombinant von Willebrand factor) does not appear to reduce blood loss following childbirth for women with von Willebrand…
The U.S. Food and Drug Administration (FDA) has expanded its approval of Vonvendi (recombinant von Willebrand factor), a treatment for von Willebrand disease (VWD).
